27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Cidara Therapeutics (NASDAQ:CDTX) reported its Q1 earnings results on Thursday, May 11, 2023 at 04:37 PM.
Here's what investors need to know about the announcement.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Earnings
Cidara Therapeutics missed estimated earnings by 25.0%, reporting an EPS of $0.03 versus an estimate of $0.04.
Revenue was up $18.88 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 18.88% drop in the share price the next day.
Here's a look at Cidara Therapeutics's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.17 | 0.18 | -0.28 | -0.29 |
| EPS Actual | -0.19 | 0.17 | -0.19 | -0.27 |
| Revenue Estimate | 10.57M | 35.67M | 6.21M | 6.11M |
| Revenue Actual | 10.22M | 40.74M | 6.22M | 7.11M |
To track all earnings releases for Cidara Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.